Screener
Jazz Pharmaceuticals JAZZ Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's net debt?
- Jazz Pharmaceuticals (JAZZ) reported net debt of $4.73B in Q1 2026.
- How has Jazz Pharmaceuticals's net debt changed year-over-year?
- Jazz Pharmaceuticals's net debt increased by 33.6% year-over-year, from $3.54B to $4.73B.
- What is the long-term trend for Jazz Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's net debt has grown at a 31.8% compound annual growth rate (CAGR), from $1.19B to $4.74B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Jazz Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude